Torrent Pharmaceuticals declines on reporting 16% fall in Q3 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Torrent Pharmaceuticals is currently trading at Rs. 2692.90, down by 467.65 points or 14.80% from its previous closing of Rs. 3160.55 on the BSE.
The scrip opened at Rs. 2940.00 and has touched a high and low of Rs. 2940.00 and Rs. 2642.05 respectively. So far 58228 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3304.45 on 31-Dec-2021 and a 52 week low of Rs. 2311.30 on 19-Mar-2021.
Last one week high and low of the scrip stood at Rs. 3225.55 and Rs. 2642.05 respectively. The current market cap of the company is Rs. 45950.32 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 20.57% and 8.18% respectively.
Torrent Pharmaceuticals has reported results for third quarter ended December 31, 2021.
The company has reported a fall of 38.85% in its net profit at Rs 170 crore for the quarter under review as compared to Rs 278 crore for the same quarter in the previous year. Total income of the company decreased by 0.12% at Rs 1625 crore for Q3FY22 as compared Rs 1627 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 16.16% in its net profit at Rs 249 crore for the quarter under review as compared to Rs 297 crore for the same quarter in the previous year. However, total income of the company increased by 7.64% at Rs 2156 crore for Q3FY22 as compared Rs 2003 crore for the corresponding quarter previous year.
